One thing I wondered - why were they so stubborn in insisting on not partnering with large pharma? Or maybe they just didn't get any interest. Either way, marketing should have been executed better, regarding the product. I wonder if it's too late for them to hire a savvy, professional marketing firm and fix things. Or maybe the damage has already been done.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.